[IKT] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
30-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -912.00%
YoY- -2,911.11%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 31/03/18 31/12/17 31/03/17 CAGR
Revenue 124 167 591 1,345 691 797 247 -24.08%
PBT -1,212 -2,344 -1,736 -1,265 -125 45 -186 111.55%
Tax -1,205 -2,339 -1,733 0 -12 0 -6 732.97%
NP -1,212 -2,344 -1,736 -1,265 -125 45 -186 111.55%
Tax Rate - - - - - 0.00% - -
Total Cost 1,337 2,511 2,327 2,610 816 753 433 56.94%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 31/03/18 31/12/17 31/03/17 CAGR
NP Margin -974.37 -1,404.30 -293.75 -94.02 -18.08 5.60 -75.05 178.67%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 31/03/18 31/12/17 31/03/17 CAGR
EPS -0.89 -1.72 -1.27 -0.74 -0.10 0.03 -0.14 109.47%
EPS Diluted -0.89 -1.72 -1.27 -0.74 -0.10 0.03 -0.14 109.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.